Y Intercept Hong Kong Ltd Decreases Stock Position in Option Care Health, Inc. $OPCH

Y Intercept Hong Kong Ltd lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 73.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 25,403 shares of the company’s stock after selling 70,673 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Option Care Health were worth $684,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of OPCH. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health during the fourth quarter valued at about $25,000. Advisory Services Network LLC purchased a new position in shares of Option Care Health in the 3rd quarter valued at approximately $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health in the 2nd quarter worth approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health in the 3rd quarter worth approximately $38,000. Finally, Quarry LP grew its position in Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.6%

Option Care Health stock opened at $21.70 on Tuesday. The business’s 50-day moving average price is $21.06 and its 200 day moving average price is $27.76. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The firm has a market cap of $3.41 billion, a price-to-earnings ratio of 16.82, a price-to-earnings-growth ratio of 1.20 and a beta of 0.65. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Insider Activity at Option Care Health

In other news, CEO John Charles Rademacher acquired 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The stock was bought at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy P. Sullivan acquired 24,154 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was purchased at an average price of $20.69 per share, with a total value of $499,746.26. Following the transaction, the director owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 73,264 shares of company stock worth $1,548,316 in the last three months. Company insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on OPCH shares. Weiss Ratings lowered shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a report on Wednesday, May 6th. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 target price on the stock. in a research report on Friday, May 1st. Barrington Research reduced their target price on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Finally, Stephens set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.